PM Group announce minority investment in Pharma Integration to advance innovative fill finish technology 'Azzurra'
PM Group is pleased to announce that it has taken a minority investment along with other parties, in Italian equipment company, Pharma Integration (PI). PI is an innovator in robotic, fill finish technology, ‘Azzurra’.
This investment follows a three-year R&D initiative that has supported the development of Azzurra – including technical design development, regulatory support, FDA engagement on ‘Emerging Technologies Programme’ and joint patent development.
The significant majority ownership and control remains with the company founders and Pharma Integration operates independently of PM Group. PM Group will continue to support the platform’s technical development to meet the Life Sciences Industry’s needs.
“We are excited to support Pharma Integration in advancing Azzurra, a technology that has the potential to transform fill finish operations in the Life Sciences sector,” said Anthony O'Rourke, CEO of PM Group. “This collaboration reflects our commitment to innovation and to technologies that bring real value to our clients and the broader industry.”
“Over the past three years PM Group have supported the development of Azzurra, our innovative fill-finish product. We are delighted to continue the relationship with PM Group as we look to bring Azzurra to the wider pharma market,” said Claudio Bechini, CEO, Pharma Integration.
PM Group will remain independent of PI in its recommendations of products to clients, whilst acknowledging our investment and close relationship.
Learn more about innovation at PM Group
This investment follows a three-year R&D initiative that has supported the development of Azzurra – including technical design development, regulatory support, FDA engagement on ‘Emerging Technologies Programme’ and joint patent development.
The significant majority ownership and control remains with the company founders and Pharma Integration operates independently of PM Group. PM Group will continue to support the platform’s technical development to meet the Life Sciences Industry’s needs.
“We are excited to support Pharma Integration in advancing Azzurra, a technology that has the potential to transform fill finish operations in the Life Sciences sector,” said Anthony O'Rourke, CEO of PM Group. “This collaboration reflects our commitment to innovation and to technologies that bring real value to our clients and the broader industry.”
“Over the past three years PM Group have supported the development of Azzurra, our innovative fill-finish product. We are delighted to continue the relationship with PM Group as we look to bring Azzurra to the wider pharma market,” said Claudio Bechini, CEO, Pharma Integration.
PM Group will remain independent of PI in its recommendations of products to clients, whilst acknowledging our investment and close relationship.
Learn more about innovation at PM Group
PM Group History with Pharma Integration
Pharma Integration, a highly innovative Italian company, has developed a fully robotic humanless modular aseptic fill finish machine – the Azzurra platform. As part of PM Group’s R&D programme, the company recognised the product’s potential and worked closely with PI to enhance the basic platform into the FAB project. This support included a high level of technical design development, regulatory support, FDA engagement on ‘Emerging Technologies Programme’ and joint patent development.
